Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nassim Kamar Laurent Alric Maeva Guillaume Stanislas Pol |
| Publication date | May 5, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |